PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
批准号:
10001471
负责人:
Wei-Xing Zong
金额:
$35.46万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2023-08-31
关键词:
1-Phosphatidylinositol 3-KinaseAblationAbnormal CellAddressAllelesAutophagocytosisBindingBiochemicalBioenergeticsBiologicalCancer ModelCell LineCell LineageCell surfaceCellsCellular Metabolic ProcessClinical DataCultured CellsDataDefectDevelopmentEmbryoEndocytosisEventFRAP1 geneFailureG-Protein-Coupled ReceptorsGTP BindingGTPase-Activating ProteinsGeneticGlucoseGrowthGrowth FactorGuanosine TriphosphateHematologic NeoplasmsHematopoieticHomeostasisHumanHydrolysisIntracellular MembranesLeadLymphocyteMCF10A cellsMalignant NeoplasmsMammary glandMediatingMembraneMetabolicMetabolic DiseasesMetabolismMolecularMonomeric GTP-Binding ProteinsMusMutationNutrientOncogenesOncogenicPIK3CA genePIK3CB genePathologicPathway interactionsPhosphotransferasesPhysiologicalProcessProtein IsoformsProtein Tyrosine KinaseProteomeReceptor SignalingReportingRoleSLC2A1 geneSignal PathwaySignal TransductionSignaling MoleculeSurfaceTestingTumor Suppressor Proteinsanimal datacell growthdeprivationdesignglucose uptakehuman diseasein vivoin vivo Modelmutantnovelphosphatidylinositol 3,4,5-triphosphatephosphatidylinositol phosphate, PtdIns(4,5)P2phosphoinositide-3,4,5-triphosphatepreventpublic health relevancereceptorresponsescaffoldsmall hairpin RNAtraffickingtumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY:
The Class IA phosphatidylinositol 3-kinases (PI3Ks) p110a and p110b isoforms are ubiquitously expressed
and respond to membrane receptor signals. They PI(3,4,5)P3, which acts as a signaling molecule to activate
downstream signaling pathways including the Akt/mTOR pathway. Despite their similarities, two isoforms have
distinct biochemical and biological features, one of which is that p110b has a kinase-independent function. We
have reported that p110b positively regulates the small GTPase Rab5 in a manner that is independent of its
catalytic activity. p110b, through a direct binding and as a molecular scaffold, keeps Rab5 in its “active” GTP-
bound form by preventing Rab5 from interacting with its GTPase-activating protein (GAP), which inactivates
Rab5 by hydrolyzing its GTP to GDP. Rab5 is well known for regulating endocytosis. Our preliminary data
strongly indicate that p110b can regulate endocytic turnover of cell surface nutrient transporters such as
glucose transporter 1 (GLUT1) in response to growth factor deprivation. We found that genetic ablation or
shRNA silencing of p110b decreased the level of Rab5-GTP. This resulted in increased cell surface GLUT1
that led to increased glucose utilization of cell lines and promoted their oncogenic transformation. These
findings lead us to propose the hypothesis that p110b, as a molecular scaffold, activates Rab5 and endocytic
turnover of nutrient transporters. We further propose that this novel function of p110b regulates membrane
trafficking and cell metabolism and homeostasis. We have designed two Specific Aims to test this hypothesis
and establish its biological relevance. Aim 1: Test the hypothesis that p110b facilitates Rab5-mediated
endocytic turnover of nutrient transporters. We will use FL5.12, MEFs, HK-2, and MCF10A cells to determine
that p110b deficiency can lead to the stabilization of nutrient transporters, and to determine if the failure of
endocytic turnover is the result of Rab5 inactivation. Aim 2. Determine the molecular and cell biological
consequence of the stabilized nutrient transporters in p110b-deficient cells (with a focus on GLUT1). We will
characterize the metabolic features associated with the nutrient transporter stabilization, and characterize the
growth/proliferation signaling in p110b-deficient cells. We will also determine the physiological effects of the
p110b-Rab5 interaction in vivo.
!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glutamine synthetase in cancer cell metabolism and oncogenesis
-
批准号:9981701
-
项目类别:
-
资助金额:$45.14万
-
财政年份:2018
-
负责人:Wei-Xing Zong
-
依托单位:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
-
批准号:10474502
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2018
-
负责人:Wei-Xing Zong
-
依托单位:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
-
批准号:10249278
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2018
-
负责人:Wei-Xing Zong
-
依托单位:
Glutamine synthetase in cancer cell metabolism and oncogenesis
-
批准号:10473698
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2018
-
负责人:Wei-Xing Zong
-
依托单位:
Phosphatidylinositol 3-kinases and Autophagy
-
批准号:9205352
-
项目类别:
-
资助金额:$36.49万
-
财政年份:2012
-
负责人:Wei-Xing Zong
-
依托单位:
Phosphatidylinositol 3-kinases and Autophagy
-
批准号:8606471
-
项目类别:
-
资助金额:$38.87万
-
财政年份:2012
-
负责人:Wei-Xing Zong
-
依托单位:
Phosphatidylinositol 3-kinases and Autophagy
-
批准号:8238446
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2012
-
负责人:Wei-Xing Zong
-
依托单位:
Phosphatidylinositol 3-kinases and Autophagy
-
批准号:8454422
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2012
-
负责人:Wei-Xing Zong
-
依托单位:
Phosphatidylinositol 3-kinases and autophagy
-
批准号:8469712
-
项目类别:
-
资助金额:$1.37万
-
财政年份:2012
-
负责人:Wei-Xing Zong
-
依托单位:
Protein and redox homeostasis in cancer development and therapy
-
批准号:10413025
-
项目类别:
-
资助金额:$32.24万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Cell death regulation in proteotoxic therapy
-
批准号:9274161
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap
-
批准号:8207955
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap
-
批准号:8020014
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Cell death regulation in proteotoxic therapy
-
批准号:8372623
-
项目类别:
-
资助金额:$31.47万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap
-
批准号:7613520
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap
-
批准号:7759542
-
项目类别:
-
资助金额:$32.17万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap
-
批准号:7466608
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Cell death regulation in proteotoxic therapy
-
批准号:8997436
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Cell death regulation in proteotoxic therapy
-
批准号:8617809
-
项目类别:
-
资助金额:$30.62万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
Protein and redox homeostasis in cancer development and therapy
-
批准号:10201520
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2008
-
负责人:Wei-Xing Zong
-
依托单位:
海外基金